{"title": "COST INFO & FINANCIAL HELP", "author": null, "url": "https://www.keytruda.com/financial-support/", "hostname": "keytruda.com", "description": "Learn about cost information and financial support with KEYTRUDA\u00ae (pembrolizumab).", "sitename": "keytruda.com", "date": "2023-01-01", "cleaned_text": "Figuring out what you might pay out of pocket for a prescription medicine can be confusing. What you pay will depend on many factors, including your insurance situation and if there are financial support options available to you. At Merck, we believe that you should be better able to understand what you can expect to pay out of your own pocket for your prescription medicine. The list price for each indicated dose of KEYTRUDA when given every 3 weeks is $10,897.12. The list price for each indicated dose of KEYTRUDA when given every 6 weeks is $21,794.24.* Most people will not pay the list price, although it may have an impact on your out-of-pocket costs. The amount you pay will depend on many factors, including your insurance situation. The information below will help you better estimate what you may pay for your prescription medicine based on your insurance situation and also cover financial assistance that may be available to you. For the actual out-of-pocket cost of your treatment, talk to your insurance provider, who knows the details of your plan if you have insurance, or contact your oncologist's office for help. *The indicated adult dose of KEYTRUDA is either 200 mg given every 3 weeks or 400 mg given every 6 weeks. KEYTRUDA is administered as an intravenous infusion. Your doctor will decide how many treatments you need. [Learn more about treatment schedules for KEYTRUDA.](/taking-keytruda) The list price does not include other treatment-related costs. The list price is current as of March 2023. The out-of-pocket costs below do not include the other medicines that you may take with KEYTRUDA or infusion center costs to administer KEYTRUDA or other medicines. If you need further information or help paying for KEYTRUDA (with or without insurance coverage), Merck may be able to help. Contact The Merck Access Program at [855-257-3932](tel:855-257-3932) (or [855-257-7332](tel:855-257-7332) for the hearing impaired). The Merck Access Program can help answer questions like: Visit The Merck Access Program website for more information and to enroll. To speak to a Merck Access Program representative: KEYTRUDA is a prescription medicine used to treat: [PD-L1](/keytruda-faq/#what-are-pd1-and-pdl1) = programmed death ligand 1; lymphoma kinase. KEYTRUDA is a medicine that may treat certain cancers by working with your immune system. KEYTRUDA can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen any time during treatment or even after your treatment has ended. Call or see your health care provider right away if you develop any signs or symptoms of the following problems or if they get worse. These are not all of the signs and symptoms of immune system problems that can happen with KEYTRUDA: Lung problems: cough, shortness of breath, or chest pain. Intestinal problems: diarrhea (loose stools) or more frequent bowel movements than usual; stools that are black, tarry, sticky, or have blood or mucus; or severe stomach-area (abdomen) pain or tenderness. Liver problems: yellowing of your skin or the whites of your eyes; severe nausea or vomiting; pain on the right side of your stomach area (abdomen); dark urine (tea colored); or bleeding or bruising more easily than normal. Hormone gland problems: headaches that will not go away or unusual headaches; eye sensitivity to light; eye problems; rapid heartbeat; increased sweating; extreme tiredness; weight gain or weight loss; feeling more hungry or thirsty than usual; urinating more often than usual; hair loss; feeling cold; constipation; your voice gets deeper; dizziness or fainting; changes in mood or behavior, such as decreased sex drive, irritability, or forgetfulness. Kidney problems: decrease in the amount of your urine; blood in your urine; swelling of your ankles; loss of appetite. Skin problems: rash; itching; skin blistering or peeling; painful sores or ulcers in your mouth or in your nose, throat, or genital area; fever or flu-like symptoms; swollen lymph nodes. Problems can also happen in other organs and tissues. Signs and symptoms of these problems may include: chest pain; irregular heartbeat; or behavior; stiff neck; balance problems; tingling or numbness of the arms or legs; double vision; blurry vision; sensitivity to light; eye pain; changes in eyesight; persistent or severe muscle pain or weakness; muscle cramps; low red blood cells; bruising. Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include chills or shaking, itching or rash, flushing, shortness of breath or wheezing, dizziness, feeling like passing out, fever, and back pain. Rejection of a transplanted organ. Your health care provider should tell you what signs and symptoms you should report and they will monitor you, depending on the type of organ transplant that you have had. Complications, including graft-versus-host disease (GVHD), in people who have received a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic). These complications can be serious and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with KEYTRUDA. Your health care provider will monitor you for these complications. Getting medical treatment right away may help keep these problems from becoming more serious. Your health care provider will check you for these problems during treatment with KEYTRUDA. They may treat you with corticosteroid or hormone replacement medicines. They may also need to delay or completely stop treatment with KEYTRUDA if you have severe side effects. Before you receive KEYTRUDA, tell your health care provider if you have immune system problems such as Crohn's disease, ulcerative colitis, or lupus; have had an organ transplant or have had or plan to have a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic); have had radiation treatment in your chest area; have a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barr\u00e9 syndrome. If you are pregnant or plan to become pregnant, tell your health care provider. KEYTRUDA can harm your unborn baby. If you are able to become pregnant, you will be given a pregnancy test before you start treatment. Use effective birth control during treatment and for 4 months after your last dose of KEYTRUDA. Tell them right away if you think you may be pregnant or you become pregnant during treatment with KEYTRUDA. Tell your health care provider if you are breastfeeding or plan to breastfeed. It is not known if KEYTRUDA passes into your breast milk. Do not breastfeed during treatment with KEYTRUDA and for 4 months after your last dose of KEYTRUDA. Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Common side effects of KEYTRUDA when used alone include feeling tired; pain, including and stomach-area (abdominal) pain; nausea; and low levels of thyroid hormone. In children, when KEYTRUDA is used alone, fever, vomiting, headache, stomach area (abdominal) pain, and low levels of white blood cells and red blood cells (anemia) are more common than in adults. Common side effects of KEYTRUDA when given with certain chemotherapy medicines include feeling tired weak; loss; inflammation of the nerves that may cause pain, weakness, and paralysis in the arms and legs; swelling of the lining of the mouth, nose, eyes, throat, intestines, or vagina; mouth sores; headache; weight loss; stomach-area (abdominal) pain; joint and muscle pain; and trouble sleeping. Common side effects of KEYTRUDA when given with chemotherapy and bevacizumab include tingling or numbness of the arms or legs; hair loss; low red blood cell count; feeling tired or weak; nausea; low white blood levels of thyroid hormone; and decreased appetite. Common side effects of KEYTRUDA when given with axitinib include diarrhea; feeling tired or weak; high blood pressure; liver problems; low levels of thyroid hormone; decreased appetite; blisters or rash on the palms of your hands and soles of your feet; nausea; mouth sores or swelling of the lining of the mouth, nose, eyes, throat, intestines, or vagina; hoarseness; rash; cough; and constipation. These are not all the possible side effects of KEYTRUDA. Talk to your health care provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit [www.fda.gov/medwatch](https://www.fda.gov/Safety/MedWatch/default.htm) or call [1-800-FDA-1088](tel:800-332-1088). Please read the accompanying [Medication Guide](http://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_mg.pdf) for KEYTRUDA and discuss it with your doctor. The physician [Prescribing Information](http://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf) also is available. [Triple-negative breast cancer (TNBC)](/triple-negative-breast-cancer/) High-risk early-stage KEYTRUDA is a prescription medicine used to treat a kind of cancer called triple-negative breast cancer (TNBC). KEYTRUDA may be used with chemotherapy medicines as treatment before surgery and then continued alone after surgery when you have early-stage breast cancer, and are at high risk of your breast cancer coming back. Advanced KEYTRUDA is a prescription medicine used to treat a kind of cancer called colon or rectal cancer. KEYTRUDA may be used when your cancer: KEYTRUDA is a prescription medicine used to treat a kind of lung cancer called [non-small cell lung cancer](/non-small-cell-lung-cancer/) (NSCLC). KEYTRUDA may be used with the chemotherapy medicines pemetrexed and a platinum as your first treatment when your lung cancer has spread (advanced NSCLC) and is a type called \"nonsquamous\" and your tumor does not have an abnormal \"EGFR\" or \"ALK\" gene. KEYTRUDA may be used with the chemotherapy medicines carboplatin and either paclitaxel or paclitaxel protein-bound as your first treatment when your lung cancer has spread (advanced NSCLC), and is a type called \"squamous.\" KEYTRUDA may be used alone as your first treatment when your lung cancer has not spread outside your chest (stage III) and you cannot have surgery or chemotherapy with radiation, or your NSCLC has spread to other areas of your body (advanced NSCLC), and your tumor tests positive for \" [PD-L1](/keytruda-faq/#what-are-pd1-and-pdl1)\" and does not have an abnormal \"EGFR\" or \"ALK\" gene. KEYTRUDA may also be used alone for [advanced NSCLC](/non-small-cell-lung-cancer/) if you have tried chemotherapy that contains platinum and it did not work or is no longer working and, your tumor tests positive for \"PD-L1\" and if your tumor has an abnormal \"EGFR\" or \"ALK\" gene, you have also received an \"EGFR\" or \"ALK\" inhibitor medicine that did not work or is no longer working. KEYTRUDA may be used alone as a treatment in adults for your lung cancer to help prevent your lung cancer from coming back after your tumor(s) has been removed by surgery and you have received platinum-based chemotherapy, and you have stage IB and your tumor(s) is 4 cm or greater in size, stage II, or stage IIIA NSCLC. [PD-L1](/keytruda-faq/#what-are-pd1-and-pdl1) = programmed death ligand lymphoma kinase. Advanced KEYTRUDA is a prescription medicine used to treat a kind of cancer that is shown by a laboratory test to be a [microsatellite instability-high](/msi-h/) ( [MSI-H](/msi-h/)) or a mismatch repair deficient ( [dMMR](/msi-h/)) solid tumor. KEYTRUDA may be used in adults and children to treat: KEYTRUDA is a prescription medicine used to treat a kind of skin cancer called [melanoma](/melanoma/). KEYTRUDA may be used: [Triple-negative breast cancer (TNBC)](/triple-negative-breast-cancer/) Advanced KEYTRUDA is a prescription medicine used to treat a kind of cancer called triple-negative breast cancer (TNBC). KEYTRUDA may be used with chemotherapy medicines when your breast cancer has returned and cannot be removed by surgery or has spread, and tests positive for \"PD-L1.\" [PD-L1](/keytruda-faq/#what-are-pd1-and-pdl1) = programmed death ligand 1. KEYTRUDA is a prescription medicine used to treat a kind of cancer called [head and neck squamous cell cancer](/head-and-neck-cancer/) (HNSCC). KEYTRUDA may be used with the chemotherapy medicines fluorouracil and a platinum as your first treatment when your head and neck cancer has spread or returned and cannot be removed by surgery. KEYTRUDA may be used alone as your first treatment when your head and neck cancer has spread or returned and cannot be removed by surgery, and your tumor tests positive for \"PD-L1.\" KEYTRUDA may be used alone when your head and neck cancer has spread or returned, and you have received chemotherapy that contains platinum and it did not work or is no longer working. [PD-L1](/keytruda-faq/#what-are-pd1-and-pdl1) = programmed death ligand 1. Advanced KEYTRUDA is a prescription medicine used to treat a kind of cancer called [cervical cancer](/cervical-cancer/) that tests positive for \" [PD-L1](/keytruda-faq/#what-are-pd1-and-pdl1).\" [PD-L1](/keytruda-faq/#what-are-pd1-and-pdl1) = programmed death ligand 1. KEYTRUDA is a prescription medicine used to treat a kind of bladder cancer called urothelial carcinoma. KEYTRUDA may be used alone when your cancer has not spread to nearby tissue in the bladder, but is at high-risk for spreading [ (high-risk, non-muscle invasive bladder cancer [NMIBC])](/non-muscle-invasive-bladder-cancer/) and when your tumor is a type called \"carcinoma in situ\" (CIS), and you have tried treatment with Bacillus Calmette-Guerin (BCG) and it did not work, and you are not able to or have decided not to have surgery to remove your bladder. Advanced KEYTRUDA is a prescription medicine used to treat a kind of uterine cancer called [advanced endometrial carcinoma.](/advanced-endometrial-cancer/) KEYTRUDA may be used alone: Advanced KEYTRUDA is a prescription medicine used to treat a kind of bladder and urinary tract cancer called urothelial carcinoma. KEYTRUDA may be used alone when your bladder or urinary tract cancer: Advanced KEYTRUDA is a prescription medicine used to treat a kind of cancer called [esophageal or certain gastroesophageal junction (GEJ) carcinomas](/esophageal-cancer/) that cannot be cured by surgery or a combination of chemotherapy and radiation therapy. [PD-L1](/keytruda-faq/#what-are-pd1-and-pdl1) = programmed death ligand 1. KEYTRUDA is a prescription medicine used to treat a kind of kidney cancer called [renal cell carcinoma (RCC)](/kidney-cancer/). KEYTRUDA may be used: KEYTRUDA is a prescription medicine used to treat a kind of skin cancer called [cutaneous squamous cell carcinoma (cSCC)](/squamous-cell-skin-cancer/). KEYTRUDA may be used when your skin cancer has returned or spread, and cannot be cured by surgery or radiation. "}